Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study. [electronic resource]
Producer: 20170911Description: 670-83 p. digitalISSN:- 1865-8652
- Adult
- Aged
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes
- Double-Blind Method
- Drug Monitoring -- methods
- Drug Therapy, Combination -- methods
- Female
- Genes, Viral
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Japan -- epidemiology
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Ritonavir -- administration & dosage
- Sulfonamides
- Treatment Outcome
- Valine
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.